000 | 01911 a2200637 4500 | ||
---|---|---|---|
005 | 20250513224032.0 | ||
264 | 0 | _c20010308 | |
008 | 200103s 0 0 eng d | ||
022 | _a0167-594X | ||
024 | 7 |
_a10.1023/a:1006477905230 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aIsobe, K | |
245 | 0 | 0 |
_aPostoperative radiation therapy for pituitary adenoma. _h[electronic resource] |
260 |
_bJournal of neuro-oncology _cJun 2000 |
||
300 |
_a135-40 p. _bdigital |
||
500 | _aPublication Type: Evaluation Study; Journal Article | ||
650 | 0 | 4 |
_aAdenoma _xchemistry |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aDose Fractionation, Radiation |
650 | 0 | 4 | _aDose-Response Relationship, Radiation |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aGerminoma |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLife Tables |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasm Proteins _xanalysis |
650 | 0 | 4 | _aNeoplasm Recurrence, Local |
650 | 0 | 4 | _aNeoplasms, Second Primary |
650 | 0 | 4 |
_aPituitary Hormones, Anterior _xanalysis |
650 | 0 | 4 |
_aPituitary Neoplasms _xchemistry |
650 | 0 | 4 | _aPostoperative Period |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aProlactinoma _xchemistry |
650 | 0 | 4 | _aProportional Hazards Models |
650 | 0 | 4 | _aRadiotherapy Dosage |
650 | 0 | 4 | _aRadiotherapy, Adjuvant |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aOhta, M | |
700 | 1 | _aYasuda', S | |
700 | 1 | _aUno, T | |
700 | 1 | _aHara, R | |
700 | 1 | _aMachida, N | |
700 | 1 | _aSaeki, N | |
700 | 1 | _aYamaura, A | |
700 | 1 | _aShigematsu, N | |
700 | 1 | _aIto, H | |
773 | 0 |
_tJournal of neuro-oncology _gvol. 48 _gno. 2 _gp. 135-40 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1023/a:1006477905230 _zAvailable from publisher's website |
999 |
_c11024732 _d11024732 |